Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight

Endocrinology
M RossiStephen R Bloom

Abstract

Melanin-concentrating hormone (MCH) has recently been proposed as both a central stimulator and an inhibitor of food intake. To clarify its role, we investigated the effects of MCH and the prepro-MCH-derived peptide neuropeptide E-I injected intracerebroventricularly (icv) in rats. MCH (0.15-15 micrograms) was injected icv at the beginning of the light phase. Food intake at 2 h showed a dose-dependent increase from 325 +/- 7% of the control value (1.5-microgram dose; P < 0.05) to 462 +/- 30% of the control value (15-microgram dose; P < 0.005). When 10 ng, 100 ng, and 5 micrograms MCH were injected icv at the beginning of the dark phase, only 5 micrograms stimulated feeding (166 +/- 16% of the control value; P < 0.05). At no dose did MCH inhibit feeding. Twice daily icv injections of MCH (5 micrograms) caused an average 197 +/- 9% increase in 2-h food intake for the first 5 days. Injections from days 6-8 did not stimulate feeding. Food intake and body weight at 24 h remained unchanged. Intracerebroventricular neuropeptide E-I had no effect on food intake alone and did not alter MCH-induced feeding. These studies show a dose-dependent stimulation of feeding by acute central administration of MCH. Tolerance is seen with chronic ad...Continue Reading

Citations

Jun 3, 2009·International Journal of Obesity : Journal of the International Association for the Study of Obesity·N M SemjonousC J Small
May 26, 2001·British Journal of Pharmacology·V AudinotJ A Boutin
Feb 28, 2002·Proceedings of the National Academy of Sciences of the United States of America·Donald J MarshSu Qian
Jul 21, 2007·Proceedings of the National Academy of Sciences of the United States of America·Hilary SandigDavid J Cousins
Jun 19, 2001·Proceedings of the National Academy of Sciences of the United States of America·A W SailerQ Liu
Dec 16, 1997·Proceedings of the National Academy of Sciences of the United States of America·J Zhu, C R Kahn
Feb 21, 1998·Proceedings of the National Academy of Sciences of the United States of America·L de LeceaJ G Sutcliffe
Dec 3, 2005·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Denis BurdakovAlexei Verkhratsky
Nov 5, 2010·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Mahesh Karnani, Denis Burdakov
Feb 13, 2001·The Journal of Clinical Investigation·D S LudwigE Maratos-Flier
Sep 4, 2007·Nutrition & Metabolism·George Wm Millington
Dec 4, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Ying Li, Anthony N van den Pol
Jun 18, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Robert M SearsRalph J DiLeone
Mar 20, 2001·General and Comparative Endocrinology·D J BirdB I Baker
Jun 3, 2014·Frontiers in Neuroendocrinology·Aaron FrankDeborah J Clegg
Aug 5, 2003·Proceedings of the National Academy of Sciences of the United States of America·Gabriella Segal-LiebermanEleftheria Maratos-Flier
Jul 31, 2001·Molecular and Cellular Endocrinology·O VerlaetenA Bernard
Feb 19, 2011·Reviews in Endocrine & Metabolic Disorders·Xiaoye Shan, Giles S H Yeo
Aug 3, 2001·Brain Research. Molecular Brain Research·A Stricker-KrongradB Beck
Aug 17, 2002·Peptides·Steven FriedBrian E Hawes
Oct 6, 2012·Biological & Pharmaceutical Bulletin·Shigeo MiyataTomie Kawada
Apr 27, 2001·Neuroscience and Biobehavioral Reviews·B Beck
Jan 18, 2007·Cell and Tissue Research·Kouhei MatsudaAkiyoshi Takahashi
Aug 28, 2004·Expert Opinion on Investigational Drugs·Timothy J Kowalski, Mark D McBriar
Jan 15, 2016·Brain Research·Alessandro BilellaMarco R Celio
Nov 9, 2011·Neuropharmacology·John C Clapham
Apr 6, 2011·General and Comparative Endocrinology·Jackson C Bittencourt
Feb 8, 2011·European Journal of Pharmacology·Rahul PanditRoger A H Adan
Nov 17, 2009·Journal of Chemical Neuroanatomy·Tatiane Araujo RondiniCarol Fuzeti Elias

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.